LOTTE Biologics and Alvotech announce US-based manufacturing agreement to increase global supply

 Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics' Syracuse facility in New York Strategic long-term partnership with Alvotech to increase their global manufacturing capacity and support growth in demand SEOUL, South Korea and REYKJAVIK, Iceland, Oct. 8, 2026 /PRNewswire/ -- LOTTE Biologics, a contract development and manufacturing (CDMO) organization, and Alvotech, a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today a long-term strategic manufacturing partne…READ FULL ARTICLE